Evi Regitz
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in ⓘ
- Genetics 13
- Chronic Lymphocytic Leukemia Research 13
-
- Lymphoma Diagnosis and Treatment 19
- Co-authors
- Michael Pfreundschuh (39 shared papers)Klaus‐Dieter Preuss (34 shared papers)Natalie Fadle (31 shared papers)Frank Neumann (16 shared papers)Joerg Thomas Bittenbring (12 shared papers)Manfred Ahlgrimm (5 shared papers)Bernd Romeike (4 shared papers)Gerhard Held (10 shared papers)
- Journals
- Blood (15 papers)International Journal of Cancer (6 papers)Journal of Autoimmunity (2 papers)Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Evi Regitz
42 papers receiving 852 citations
Peers
Comparison fields: 5 of 70
- Immunology 328
- Genetics 150
- Pathology and Forensic Medicine 232
- Hematology 105
- Neurology 140
Countries citing papers authored by Evi Regitz
This map shows the geographic impact of Evi Regitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evi Regitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evi Regitz more than expected).
Fields of papers citing papers by Evi Regitz
This network shows the impact of papers produced by Evi Regitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evi Regitz. The network helps show where Evi Regitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Evi Regitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 96 | |
| 2 | 2005 | 71 | |
| 3 | 2012 | 55 | |
| 4 | 2001 | 48 | |
| 5 | 2011 | 48 | |
| 6 | 2009 | 43 | |
| 7 | 2004 | 41 | |
| 8 | 2014 | 37 | |
| 9 | Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. | 2003 | 37 |
| 10 | 2002 | 33 | |
| 11 | 2009 | 33 | |
| 12 | Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas. | 2003 | 33 |
| 13 | 2013 | 33 | |
| 14 | 2013 | 31 | |
| 15 | 2011 | 24 | |
| 16 | 2006 | 22 | |
| 17 | 2011 | 22 | |
| 18 | 2014 | 20 | |
| 19 | Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2. | 2003 | 18 |
| 20 | 2018 | 17 |
About Evi Regitz
Evi Regitz is a scholar working on Genetics, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Hematology, having authored 46 papers that have together received 864 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Chronic Lymphocytic Leukemia Research (13 papers), Immunotherapy and Immune Responses (7 papers), Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). The work is most often cited by research in Immunology (328 citations), Genetics (150 citations), Pathology and Forensic Medicine (232 citations), Hematology (105 citations) and Neurology (140 citations). Evi Regitz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michael Pfreundschuh, Klaus‐Dieter Preuss, Natalie Fadle, Frank Neumann, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Bernd Romeike, Gerhard Held, Boris Kubuschok and Lorenz Thurner. Their work appears in journals such as Blood, International Journal of Cancer, Journal of Autoimmunity, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.